Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

NCT00886028 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER_GOV

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Liposomal doxorubicin
DRUG: Cisplatin

Sponsor

National Institute of Cancerología